Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levels

Statistics in Medicine

Volumn 25, Issue 17, 2006, Pages 2994-3010

  Baughman, Andrew L ^a   Bisgard, Kristine M ^a,c   Lynn, Freyja ^b   Meade, Bruce D ^b  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Antibodies; Diagnostic cut off point; Mixture model; Pertussis; Third National Health and Nutrition Examination Survey

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; BORDETELLA PERTUSSIS; CONTROLLED STUDY; HUMAN; PERTUSSIS; QUANTITATIVE ASSAY; SAMPLE SIZE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; PERTUSSIS TOXIN; WHOOPING COUGH;

EID: 33747586958     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2442     Document Type: Article

References (52)

1. Marchant CD, Loughlin AM, Lett SM, Todd CW, Wetterlow LH, Bicchieri R, Higham S, Etkind P, Silva E, Siber GR. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. The Journal of Infectious Diseases 1994; 169:1297-1305.
2. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. The Journal of Infectious Diseases 2000; 182:1409-1416.
3. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, Amundson G, Baughman A, Wattigney W. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. The Journal of Infectious Diseases 2001; 183:1353-1359.
4. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. The Journal of lnfectious Diseases 1996; 173:1256-1259.
5. Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Applied Occupational and Environmental Hygiene 1990; 5:46-51.
6. Parker RA, Erdman DD, Anderson LJ. Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application of parvovirus B19 serology. Journal of Virological Methods 1990; 27:135-144.
7. Thompson TJ, Smith PJ, Boyle JP. Finite mixture models with concomitant information: assessing diagnostic criteria for diabetes. Applied Statistics 1998; 47:393-404.
8. Lawrence CJ, Trewin VF. The construction of biochemical reference ranges and the identification of possible adverse drug reactions in the elderly. Statistics in Medicine 1991; 10:831-837.
9. Moulton LH, Halsey NA. A mixture model with detection limits for regression analyses of antibody response to vaccine. Biometrics 1995; 51:1570-1578.
10. Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, Holland K, Meade BD, Lynn F. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clinical and Diagnostic Laboratory Immunology 2004; 11:1045-1053.
11. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Vital and Health Statistics 1994; 1(32).
12. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: third National Health and Nutrition Examination Survey. Vital and Health Statistics 1992; 2(113).
13. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Household Youth Data File (CD-ROM). Public Use Data File Documentation Number 77550. Centers for Disease Control and Prevention: Hyattsville, MD, 1996.
14. DHHS. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Household Adult Data File (CD-ROM). Public Use Data File Documentation Number 77560. Centers for Disease Control and Prevention: Hyattsville, MD, 1996.
15. Meade BD, Deforest A, Edwards KM, Romani TA, Lynn F, O'Brien CH, Swartz CB, Reed GF, Deloria MA. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995; 96:570-575.
16. Centers for Disease Control and Prevention. Pertussis-United States, 1997-2000. Morbidity and Mortality Weekly Report 2002; 51:73-76.
17. Christie CD, Marx ML, Marchant CD, Reising SF. The 1993 epidemic of pertussis in Cincinnati - resurgence of disease in a highly immunized population of children. The New England Journal of Medicine 1994; 331:16-21.
18. Hardy IR, Strebel PM, Wharton M, Orenstein WA. The 1993 pertussis epidemic in Cincinnati [letter]. The New England Journal of Medicine 1994; 331:1455-1456.
19. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. The Journal of Infectious Diseases 1995; 171:1650-1652.
20. Kenyon TA, Izurieta H, Shulman ST, Rosenfeld E, Miller M, Daum R, Strebel PM. Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness. The Pediatric Infectious Disease Journal 1996; 15:655-661.
21. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clinical Infectious Diseases 1999; 28:1230-1237.
22. Lambert HJ. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Reports 1965; 80:365-369.
23. Le T, Cherry JD, Chang S-J, Knoll MD, Lee ML, Barenkamp S, Bernstein D, Edelman R, Edwards KM, Greenberg D, Keitel W, Treanor J, Ward JI. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT study. The Journal of Infectious Diseases 2004; 190:535-544.
24. Mortimer EA. Pertussis and its prevention: a family affair. The Journal of Infectious Diseases 1990; 161:473-479.
25. Versteegh FGA, Schellekens JFP, Nagelkerke AF, Roord JJ. Laboratory-confirmed reinfections with Bordetella pertussis. Acta Paediatrica 2002; 91:95-99.
26. Teunis PFM, van der Heijden OG, de Melker HE, Schellekens JFP, Versteegh FGA, Kretzschmar MEE. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection 2002; 129:479-489.
27. Arico B, Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. Journal of Bacteriology 1987; 169:2847-2853.
28. Schmitt-Grohe S, Cherry JD, Heininger U, Uberall MA, Pineda E, Stehr K. Pertussis in German adults. Clinical Infectious Diseases 1995; 21:860-866.
29. Hodder SL, Cherry JD, Mortimer EA, Ford AB, Gornbein J, Papp K. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clinical Infectious Diseases 2000; 31:7-14.
30. McLachlan G, Peel D. Finite Mixture Models. Wiley: New York, 2000.
31. McLachlan GJ, McGiffin DC. On the role of finite mixture models in survival analysis. Statistical Methods in Medical Research 1994; 3:211-226.
32. Yamaguchi K. Accelerated failure-time regression models with a regression model of surviving fraction: an application to the analysis of 'permanent employment' in Japan. Journal of the American Statistical Association 1992; 87:284-292.
33. Peng Y, Dear KBG, Denham JW. A generalized F mixture model for cure rate estimation. Statistics in Medicine 1998; 17:813-830.
34. Korn EL, Graubard BI. Analysis of Health Surveys. Wiley: New York, 1999.
35. Wedel M, ter Hofstede F, Steenkamp J-BEM. Mixture model analysis of complex samples. Journal of Classification 1998; 15:225-244.
36. McLachlan GJ, Krishnan T. The EM Algorithm and Extensions. Wiley: New York, 1997.
37. SAS Institute Inc. The NLP procedure. In SAS/OR User's Guide: Mathematical Programming, Version 8. SAS Institute Inc.: Cary, NC, 1999.
38. Emerson JD, Stoto MA. Transforming data. In Understanding Robust and Exploratory Data Analysis, Hoaglin DC, Mosteller F, Tukey JW (eds). Wiley: New York, 1983; 97-128.
39. Gutierrez RG, Carroll RJ, Wang N, Lee G-H, Taylor BH. Analysis of tomato root initiation using a normal mixture distribution. Biometrics 1995; 51:1461-1468.
40. Zhou XH, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. Wiley: New York, 2002; 15-56,
41. Hahn GJ, Meeker WQ. Statistical Intervals: A Guide for Practitioners. Wiley: New York, 1991.
42. Meade BD, Mink CM, Manclark CR. Scrodiagnosis of pertussis. In Proceedings of the 6th International Symposium on Pertussis, Manclark CR (ed.), DHHS no. (FDA) 90-1164, 1990; 322-329.
43. Steketee RW, Burstyn DG, Wassilak SGF, Adkins WN, Polyak MB, Davis JP, Manclark CR. A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. The Journal of Infectious Diseases 1988; 157:441-449.
44. Kramer MS. Clinical Epidemiology and Biostatistics. Springer: New York, 1988; 201-219.
45. Murphy EA, Abbey H. The normal range - a common misuse. Journal of Chronic Diseases 1967; 20:79-88.
46. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. The Journal of Infectious Diseases 1996; 174:89-96.
47. Lind-Brandberg L, Welinder-Olsson C, Lagergard T, Taranger J, Tollfors B, Zackrisson G. Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella paropertussis infections. Journal of Clinical Microbiology 1998; 36:679-683.
48. Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children-recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 1997; 46(RR-7):1-25.
49. Everitt BS, Hand DJ. Finite Mixture Distributions. Chapman & Hall: London, 1981; 44-45.
50. Aitkin M, Aitkin I. A hybrid EM/Gauss-Newton algorithm for maximum likelihood in mixture distributions. Statistics and Computing 1996; 6:127-130.
51. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. Prentice-Hall: Englewood Cliffs, NJ, 1992; 596-602.
52. SAS Institute Inc. The FASTCLUS procedure. In SAS/STAT User's Guide, Version 6 (4th edn), vol. 1. SAS Institute Inc.: Cary, NC, 1989.